Join BioArctic for Their Third Quarter Report Presentation
BioArctic AB (publ) announces the upcoming release of its third quarter report for July to September 2025. The report will be published on Thursday at 08:00 a.m. CET.
Invitation to the Presentation
Investors, analysts, and media representatives are welcome to participate in an informative audiocast and teleconference scheduled for the same day at 09:30 a.m. CET. During this event, CEO Gunilla Osswald and CFO Anders Martin-Löf will provide insights and commentary on the quarterly results, followed by a Q&A session to engage with participants.
How to Participate
For those interested in attending via webcast, access will be available for submitting written questions throughout the presentation.
Teleconference Registration and Access
Participants wishing to join the teleconference should register beforehand. By doing so, they will receive the necessary phone numbers and conference ID to access the call, allowing for real-time verbal questions.
On-Demand Webcast
The recorded audiocast will also be available later on BioArctic's corporate website, ensuring that interested parties can view the presentation at their convenience.
Contact Information
For further inquiries, please contact Oskar Bosson, VP of Communications and Investor Relations, at +46 704 10 71 80.
About BioArctic AB
BioArctic AB is a renowned Swedish biopharma company dedicated to innovative solutions targeting neurodegenerative diseases. Among its notable achievements, the company developed Leqembi, recognized as the first treatment that can effectively slow the progression of early Alzheimer's disease. Partnered with Eisai, BioArctic focuses on furthering research and commercialization within the sector. The company is expanding its portfolio with potential treatments for diseases such as ALS and Parkinson's disease, utilizing their proprietary BrainTransporter technology that enhances drug efficiency.
Frequently Asked Questions
What is the date and time of BioArctic's presentation?
The presentation will take place on November 13, 2025, at 09:30 a.m. CET.
Who will present during the event?
CEO Gunilla Osswald and CFO Anders Martin-Löf will lead the presentation along with their colleagues.
How can I participate in the audiocast?
You can participate by joining the webcast, where you can submit written questions for discussion.
What should I do if I want to join the teleconference?
Please register in advance to receive the phone numbers and conference ID necessary for joining the teleconference.
Where can I find more information about BioArctic?
For detailed information about BioArctic's ongoing projects and updates, visit their official website.